1. GSK settles US Zantac lawsuit for $2.2bn
The plaintiffs alleged the drug caused cancer, although GSK maintains there is no evidence linking Zantac to an increased cancer risk and has not admitted liability.
2. Excitement ahead of Tesla Robotaxi launch
CEO Elon Musk may also discuss deploying the company’s full self-driving software on its semi-big rig.
3. Ryanair to slash German flights in protest of high taxes and fees
Up to 1.8 million seats will be cut across 22 routes, with the airline ceasing all flights to Dortmund, Dresden and Leipzig.
4. Indivior plunges on profit warning as rival anti-opioid product sells faster than expected
Management of the group now sees lower than expected revenue from Sublocade in the third quarter and full year from a combination of faster initial adoption of a competitor's rival long-acting injectable treatment, as well as other factors.
5. FTSE 100 Live
Stocks in red.